Evidence map›Paper›PMID 30545302›Full record

ArticleBMC genomics2018

When pitch adds to volume: coregulation of transcript diversity predicts gene function.

Alejandro Cáceres, Juan R González

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 88% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Alejandro CáceresISGlobal, 08003, Barcelona, Spain. alejandro.caceres@isglobal.org.ORCID http://orcid.org/0000-0001-8551-6695
Juan R GonzálezISGlobal, 08003, Barcelona, Spain. juanr.gonzalez@isglobal.org.
Barcelona Institute for Global Health · ESUniversitat Autònoma de Barcelona · ES

Funding

Ministerio de Economía e Innovación MTM2015-68140-RRed Española de Supercomputación BCV-2016-3-0002
6 · The paper itself

Abstract

backgroundGenes corregulate their overall transcript volumes to perform their physiological functions. However, it is unknown if they additionally coregulate their transcript diversities. We studied the reliability, consistency and functional associations of co-splicing correlations of genes of interest, across two independent studies, multiple tissues and two statistical methods. We thoroughly investigated the reproducibility of co-splicing correlations of APP, the candidate gene of Azheimer's disease (AD). We then studied how co-splicing correlations in different tissues contributed to predict functional interactions of three other genes and finally computed co-splicing frequency for 17 thousand genes across 52 human tissues.

resultsWe replicated co-splicing correlations between APP and 5 AD-related genes and reproduced expected enrichment of APP co-splicing in synaptic vesicle cycle and proteosome pathways. We observed novel associations for tissue vulnerability to disease with enrichment in APP co-splicing, co-expression and epistasis in AD. APP co-splicing was the strongest predictor and replicated between studies. We confirmed known gene interactions of PRPF8 and GRIA1 in testis and brain cortex, and observed a novel interaction of FGFR2, in breast and prostate, modulated by cancer risk-variants. We produced a co-splicing map across 52 human tissues to help predict the function of over 17 thousand genes.

conclusionsWe show that coregulation of transcript diversities provides novel biological insights in gene physiology and helps to interpret GWAS results. Co-splicing correlations are reliable and frequent and should be further pursued to help predict gene function. Our results additionally support current AD interventions aiming at the ubiquitin proteosome pathway but unveil the need to consider transcript diversity in addition to volume to assess treatment response and susceptibility to the disease.

Indexed as

Adaptor Proteins, Signal TransducingAlternative SplicingAlzheimer DiseaseAmyloid beta-Protein PrecursorAutophagy-Related ProteinsBreastCarrier ProteinsCell Cycle ProteinsFemaleHippocampusHumansMalePolymorphism, Single NucleotideReceptor, Fibroblast Growth Factor, Type 2Receptors, AMPARNAAdaptor Proteins, Signal TransducingAmyloid beta-Protein PrecursorAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsFGFR2 protein, humanPRPF8 protein, humanReceptor, Fibroblast Growth Factor, Type 2Receptors, AMPARNARNA-Binding ProteinsScavenger Receptors, Class BSSc5D protein, humanUBQLN1 protein, humanAlternative splicingAlzheimer’s diseaseCo-splicingEpistasisGene function predictionRNA-sequencingTranscription diversityTranscriptome

Identifiers

PMID30545302
PMCPMC6293560
OpenAlexW2905217491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.